Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06073756

Neutrophil-lymphocyte and Platelet-lymphocyte Ratios and Their Relations to Vascular Comlications and Glycemic Control in Patients With Type 2 Diabetes Attending The Diabetes Center of Assiut University Hospitals

Evaluate PLR and NLR and their assiotation to vascular complications and glycemic control in type 2 DM

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

Vascular complications of DM result from various disorders including metabolic, cellular, and blood disturbances. Excessive production of pro-inflammatory adipokines from adipose tissue, resulting in low-grade chronic inflammation, causing insulin resistance (IR) and type 2 DM [3]. Hematological changes affecting the red blood cells (RBCs), white blood cells (WBCs), platelet function, and the coagulation factors are detected to be associated with DM . It is important to add that, high WBC count, one of the chief components of inflammatory process, sharing to atheroscle-rosis development and cardiovascular diseases (CVD) . Lately, the neutrophil-to-lymphocyte (N/L) and the platelet-to-lymphocyte (P/L) ratios, were offered as markers of inflammation in cardiac diseases, neoplasms and diabetes-related complications . Moreover, high leucocyte counts have been used as diagnostic and prognostic markers in vascular complication of diabetes

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Type 2 diabetes mellitus (T2DM) patients with good glycemic control and have HBA1C <7and ages ranging from ≥18 old. And poor glycemic control and have HBA1C ≥7 and ages rang from ≥ 18 years old

Exclusion criteria

  • Patients with, type 1 diabetes mellitus
  • Idiopathic thrombocytopenic purpura,
  • liver cell failure
  • Myeloproliferative neoplasm
  • patients on anticoagulant drugs , anti platelet drugs or on steroids were excluded from the study

Treatment and study plan

Echocardiogram

Radiation

Evaluate PLR and NLR and their assiotation to vascular complications and glycemic control in type 2 DM

Other names: ALB / cr ratio, Fundus examination, ECG, Doppler on lower limbs, Nerve conduction, Echo

Primary outcomes

  1. Neutrophil-to-lymphocyte ratio and platelets to lymphocytes ratio

    Time frame: Basline

    Measurement of Neutrophils to lymhocyte ratio and platelets to lymhocyte ratio in patients with type 2 DM

Secondary outcomes

  1. HbA1c with good glycemic control and have HBA1C lower than 7and poor glycemic control and have HBA1C higher than 7with prescence or abscence of vascular complications

    Time frame: Basline

    Evaluate PLR and NLR and their assiotation to vascular complications and glycemic control in type 2 DM

Study contacts

Contact information is provided by the study sponsor or research team.

Ammar Ashraf Fathy

CONTACT

[email protected]

01028177808

Salah abdelazem Argoon

CONTACT

[email protected]

01019683366

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Important dates

Study start
2023
Primary completion
2027
Study completion
2027
First posted
Oct 10, 2023
Registry last updated
Oct 10, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.